According to Dermapharm's latest financial reports the company's current EPS (TTM) is $4.24. In 2022 the company made an earnings per share (EPS) of $4.65 a decrease over its 2021 EPS that were of $8.05.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $3.90 | -16.17% |
2022 | $4.65 | -42.21% |
2021 | $8.05 | 144.18% |
2020 | $3.30 | 14.58% |
2019 | $2.88 | -3.15% |
2018 | $2.97 | -34.2% |
2017 | $4.52 |